Latest Insider Transactions at Aptose Biosciences Inc. (APTO)
This section provides a real-time view of insider transactions for Aptose Biosciences Inc. (APTO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Aptose Biosciences Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Aptose Biosciences Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 25
2024
|
William G. Rice Chair, President & CEO |
BUY
Open market or private purchase
|
Direct |
100,000
+14.02%
|
$0
$0.2 P/Share
|
|
Sep 22
2023
|
Bernd R. Seizinger |
BUY
Open market or private purchase
|
Direct |
17,000
+50.0%
|
$51,000
$3.14 P/Share
|
|
Jan 19
2023
|
William G. Rice Chair, President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+22.62%
|
-
|
|
Jan 19
2023
|
Philippe Ledru |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+49.88%
|
-
|
|
Jan 19
2023
|
Fletcher Payne Sr VP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+50.0%
|
-
|
|
Jan 19
2023
|
Rafael Bejar Sr VP & Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+47.62%
|
-
|
|
Sep 19
2022
|
William G. Rice Chair, President & CEO |
BUY
Open market or private purchase
|
Direct |
10,000
+2.68%
|
$0
$0.68 P/Share
|
|
Sep 19
2022
|
Fletcher Payne Sr VP and CFO |
BUY
Open market or private purchase
|
Indirect |
10,000
+50.0%
|
$0
$0.68 P/Share
|
|
Jun 06
2022
|
William G. Rice Chair, President & CEO |
BUY
Open market or private purchase
|
Direct |
10,000
+2.75%
|
$0
$0.97 P/Share
|
|
Dec 20
2021
|
Denis R Burger |
BUY
Open market or private purchase
|
Direct |
10,000
+24.0%
|
$10,000
$1.45 P/Share
|
|
Dec 16
2021
|
Erich Platzer |
BUY
Open market or private purchase
|
Direct |
100,000
+6.51%
|
$100,000
$1.38 P/Share
|
|
Dec 16
2021
|
William G. Rice Chair, President & CEO |
BUY
Open market or private purchase
|
Direct |
13,183
+3.7%
|
$13,183
$1.52 P/Share
|
|
Dec 15
2021
|
Erich Platzer |
BUY
Open market or private purchase
|
Direct |
270,000
+16.88%
|
$270,000
$1.18 P/Share
|
|
Dec 15
2021
|
William G. Rice Chair, President & CEO |
BUY
Open market or private purchase
|
Direct |
17,822
+5.12%
|
$17,822
$1.12 P/Share
|
|
Nov 26
2021
|
William G. Rice Chair, President & CEO |
BUY
Open market or private purchase
|
Direct |
8,643
+2.69%
|
$17,286
$2.31 P/Share
|
|
Nov 19
2021
|
Rafael Bejar Sr VP & Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$20,000
$2.56 P/Share
|
|
Nov 19
2021
|
Denis R Burger |
BUY
Exercise of conversion of derivative security
|
Direct |
5,417
+20.0%
|
$10,834
$2.04 P/Share
|
|
Aug 05
2021
|
Donald R. Wilson Jr. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
60,000
-0.67%
|
$120,000
$2.62 P/Share
|
|
Aug 03
2021
|
Donald R. Wilson Jr. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
57,199
+0.64%
|
$114,398
$2.65 P/Share
|
|
Jul 02
2021
|
William G. Rice Chair, President & CEO |
BUY
Open market or private purchase
|
Direct |
6,081
+1.96%
|
$18,243
$3.29 P/Share
|
|
Jun 22
2021
|
Warren Whitehead |
SELL
Open market or private sale
|
Direct |
9,600
-39.02%
|
$28,800
$3.24 P/Share
|
|
Jun 21
2021
|
Warren Whitehead |
SELL
Open market or private sale
|
Direct |
15,400
-38.5%
|
$46,200
$3.35 P/Share
|
|
Dec 22
2020
|
Warren Whitehead |
SELL
Open market or private sale
|
Direct |
20,000
-18.33%
|
$80,000
$4.06 P/Share
|
|
Dec 22
2020
|
Warren Whitehead |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+25.0%
|
$40,000
$2.01 P/Share
|